AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

NCT00107250 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Colorectal Cancer
Lung Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: capecitabine
DRUG: carboplatin
DRUG: cediranib maleate
DRUG: paclitaxel

Sponsor

NCIC Clinical Trials Group